Jason T. Eberl, Ph.D. is the Semler Endowed Chair for Medical Ethics in the College of Osteopathic Medicine at Marian University. Dr. Eberl received his BA degree from the University of San Diego with majors in Philosophy and Spanish, and a minor in Psychology. He earned his MA in Philosophy at Arizona State University and Ph.D. at Saint Louis University. During his doctoral studies, he was a visiting research student at the Center for Philosophy of Religion at the University of Notre Dame and the Johann Wolfgang Goethe Universität in Frankfurt am Main, Germany.
From 2003 to 2013, Dr. Eberl held a tenure-line appointment—as first assistant and later tenured associate professor—in the Department of Philosophy in the IU School of Liberal Arts at IUPUI. He was also the director of graduate studies for a master of arts degree program in philosophy with concentrations in bioethics and international research ethics. As part of this graduate program, Dr. Eberl and his colleagues designed combined-degrees curricula with law (JD/MA), medicine (MD/MA), and public health (MPH/MA). He continues to serve on the program leadership team for the Academic Research Ethics Partnership between IU and Moi University in Eldoret, Kenya, which is funded by a grant from the Fogarty International Center at the National Institutes of Health.
In 2006, Dr. Eberl published his first book, Thomistic Principles and Bioethics, as part of the Annals of Bioethics series at Routledge Press. In Spring 2012, he was a visiting research fellow at the Centre for Ethics, Philosophy, and Public Affairs at the University of St. Andrews in Scotland. Dr. Eberl’s research interests focus on medical ethics, metaphysics, and medieval philosophy. He is particularly interested in the thought of the 13th century philosopher and theologian St. Thomas Aquinas and how his theories of human nature and morality may inform the ethical evaluation of various issues in medical ethics, including those at the margins of human life—such as abortion, human embryonic stem cell research, the definition of death, euthanasia, and organ donation—as well as emerging issues in genetics—such as reproductive cloning, genetic enhancement, and the creation of human/non-human chimeras—and justice in the allocation of health care resources.
Dr. Eberl is a member of the American Catholic Philosophical Association, American Philosophical Association, American Society for Bioethics and Humanities, National Catholic Bioethics Center, and Society of Christian Philosophers. In 2008, he received the ACPA Young Scholar’s Award.
Eric M. Meslin, Ph.D. is founding director of the Indiana University Center for Bioethics which celebrated its 10th anniversary in 2011. He is also Associate Dean for Bioethics in the Indiana University School of Medicine, and is Professor of Medicine; of Medical & Molecular Genetics; of Public Health; and of Philosophy. In 2012 he was appointed Indiana University’s first endowed Professor of Bioethics and is a member of Indiana University’s Alliance of Distinguished and Titled Professors.
Among his other leadership positions at IU he directs the Indiana University-Moi University Academic Research Ethics Partnership, an NIH-funded bioethics training program in Eldoret, Kenya; the Bioethics and Subject Advocacy Program of the Indiana Clinical and Translational Science Institute; and co-directs the Indiana University Center for Law, Ethics and Applied Research in Health Information (CLEAR).
Born in Canada, Dr. Meslin received his B.A. from York University (Toronto), and his M.A. and Ph.D. from Georgetown University. Prior to coming to Indiana, he was director of bioethics research for the ELSI program at the National Human Genome Research Institute (1996-98), and Executive Director of the U.S. National Bioethics Advisory Commission (1998-2001) appointed by President Bill Clinton.
He has held academic positions at the University of Toronto (1988-96); as Visiting Fellow at Green College, University of Oxford (1994-95); and as Professor-at-Large at the University of Western Australia (2008-2010). During 2012-2013 he was on sabbatical as the Pierre de Fermat Chaire d’Excellence at the Université de Toulouse.
Dr. Meslin has more than 150 published articles and book chapters on various topics in bioethics and science, is a co-editor of the Cambridge University Press Bioethics and Law Series, and the Indiana University Press Bioethics and Humanities Series. He has been a member of several boards and committees in the U.S. and Canada including the Institute of Medicine’s Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; the Ethics Subcommittee, Advisory Committee to the Director of the U.S. Centers for Disease Control and Prevention in Atlanta; and the Board of Directors of Canada’s Stem Cell Network Centre of Excellence. Canada. He is a current member of Science and Industry Advisory Committee of Genome Canada.
On May 9, 2007 he was appointed a Chevalier de L’Order Nationale du Mérite (Knight of the National Order of Merit) by the French Ambassador to the United States for contributions to French bioethics policy.
Luann E. Van Campen is Senior Advisor and Head of the Lilly Bioethics Program at Eli Lilly and Company. Since 2008, she has been the Company’s bioethics technical expert and has developed and led the Company’s innovative bioethics initiatives. She serves as the executive secretary of the Lilly Bioethics Advisory Committee (BEAC). Dr. Van Campen also serves on several academic and professional ethics working groups. Prior to this role, Dr. Van Campen was a Scientific Communications Consultant and was responsible for developing policies, procedures, processes, and tools for global scientific publishing across the lifecycle of compound development. She also coordinated scientific communications for two Lilly Neuroscience drugs. Dr. Van Campen’s Lilly contributions have been recognized with several awards including, the Lilly Research Laboratories President’s Award, the Six Sigma Black Belt Team Excellence Award, two Quality Advocate Awards, and “They’re Making a Difference” Recognition.
Before joining Lilly in 2000, Dr. Van Campen worked in the fields of hearing science and clinical audiology for 13 years. She completed her clinical fellowship with Vanderbilt University Medical School and the Bill Wilkerson Center (Nashville, TN), and then served on the faculty of the University of Oklahoma Health Sciences Center (Oklahoma City, OK) in the Otorhinolaryngology department. During her faculty tenure, she was the lead investigator for a multi-site, longitudinal study examining the auditory and vestibular sequelae following the Oklahoma City Bombing and served on a national Blast Injuries Studies Steering Committee. Subsequent to this, she was a visiting scientist with the Centers for Disease Control and Prevention's (CDC), National Institute for Occupational Safety and Health (NIOSH) (Cincinnati, OH). Dr. Van Campen has co-authored a variety of scientific articles and presentations. Her specialties include evoked potentials, auditory and vestibular diagnostics, blast trauma, noise exposure, mood disorders, scientific publishing, and bioethics.
Dr. Van Campen earned a BS in Speech Pathology and Audiology from Miami University (Oxford, OH), a MS in Audiology with a minor in Psychology from Purdue University (West Lafayette, IN), a PhD in Hearing Science with a minor in Neuroscience from Vanderbilt University (Nashville, TN), and a MA in Bioethics from Trinity International University (Deerfield, IL).
| || |
Tuesday, February 25, 2014
Marian University Theatre
Jason T. Eberl, Ph.D
Semler Endowed Chair for Medical Ethics
College of Osteopathic Medicine
Eric M. Meslin, Ph.D.
Director, Indiana University
Center for Bioethics
Associate Dean for Bioethics
Professor of Bioethics
Indiana University School of Medicine
Luann E. Van Campen, Ph.D., M.A.-Bioethics
Sr Advisor and Head of Bioethics Program
Eli Lilly and Company
The Center for Organizational Ethics at Marian University